Radioimmunoassay Market: By Type, By End User, By Application & By Region - Forecast 2016-2021

  • ID: 3974186
  • Report
  • 142 pages
  • IndustryARC
1 of 3
The technique of radioimmunoassay (RIA) is advanced and sensitive technology to find small molecules in the blood, hence this technology is used for research purposes and diagnosis of diseases, such as cancer. Radioimmunoassay (RIA) high precision, robust, and impeccable sensitivity and is one of the pivotal, methods used for the testing of endocrinological disorders. RIA also has a prominent usage in the field of neurodegenerative disorders. Globally increasing number of patients with cancer and other infectious diseases is expected to drive the demand for the radioimmunoassay market during the period of study.

Geographically Europe accounts for the largest market shares in global radioimmunoassay market owing to advancements in medical research, clinical trials, growing geriatric population with cancer indication. Also prevalence of various other infectious diseases in the region is expected to drive the radioimmunoassay market growth in the near future. Europe was followed by North America and Asia-Pacific as second and third largest market for radioimmunoassay market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure, increased spending by pharmaceutical industries over research and development to develop new molecules and capture higher market share in this growth potential market, government initiatives and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global radioimmunoassay market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global radioimmunoassay market.

This report segments global radioimmunoassay market on the basis of type, application and end-user and regional market as follows:
Radioimmunoassay Market, By Type: Reagents & Kits, and Analyzers
Radioimmunoassay Market, By End-User: Hospital, Pharmaceutical Industry, Academics, and Clinical Diagnostic Labs
Radioimmunoassay Market, By Application: Research, and Clinical Diagnostics
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the radioimmunoassay market. Some of the major companies’ profiles in detail are as follows:
Diasorin S.P.A.

Euro Diagnostica AB
Merck Millipore Corporation
Diasource Immunossays S.A
Stratec Biomedicals AG
Berthold Technologies Gmbh & Co. Kg
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Radioimmunoassay Market – Market Overview

2. Executive Summary

3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Radioimmunoassay Market– Market Forces
4.1. Drivers
4.1.1. Technological Advancement
4.1.2. Growing Number of Patients with Cancer and other infectious diseases
4.2. Restraints
4.2.1. Lack of Adequate Infrastructure & Healthcare Expenditure
4.3. Opportunities
4.3.1. Emerging Markets Offer Numerous Growth Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Radioimmunoassay Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Radioimmunoassay Market, By Type
6.1. Reagents & Kits
6.2. Analyzers

7. Radioimmunoassay Market, By End-User
7.1. Hospital
7.2. Pharmaceutical Industry
7.3. Academics
7.4. Clinical Diagnostic Labs

8. Radioimmunoassay Market, By Application
8.1. Research
8.2. Clinical Diagnostics

9. Radioimmunoassay Market, By Geography
9.1. Europe
9.1.1. Germany
9.1.2. France
9.1.3. Italy
9.1.4. Spain
9.1.5. Russia
9.1.6. U.K.
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.1. China
9.2.2. India
9.2.3. Japan
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America
9.3.1. U.S.
9.3.2. Canada
9.3.3. Mexico
9.4. Rest of the World (RoW)
9.4.1. Brazil
9.4.2. Rest of RoW

10. Radioimmunoassay – Market Entropy
10.1. Expansion
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. Diasorin S.P.A.
11.2. Euro Diagnostica AB
11.3. Merck Millipore Corporation
11.4. Diasource Immunossays S.A
11.5. Stratec Biomedicals AG
11.6. Berthold Technologies Gmbh & Co. Kg
11.7. Izotop
11.8. Beckman Coulter, Inc.
11.9. Cisbio
11.10. MP Biomedicals LLC
11.11. Perkinelmer, Inc.
11.12. IBL International (A Tecan Company)
11.13. DRG International, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown
Order Online - visit: